Funded Local Who is raising money in your own backyard?

Vancouver, July 30, 2008 - IP Applications Corp. (TSX-V: IPX) (the “Company”) is pleased to announce that further to the Company’s news release of June 20, 2008, it has received final acceptance from the TSX Venture Exchange and formally closed its non-brokered private placement of 3,875,000 Units, at a price of $0.20 per Unit, raising gross proceeds of $775,000. Each Unit consisted of one common share and one-half common share purchase warrant.

Vancouver- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has entered into an agreement with CR Intrinsic Investments, LLC, an investment fund managed by CR Intrinsic Investors, LLC, an affiliate of S.A.C. Capital Advisors, LLC to purchase Series A convertible preferred shares for gross proceeds of US$25 million. Proceeds of the financing will be used for general corporate purposes, costs associated with the ongoing strategic process and continued development of Cardiome’s clinical programs.

Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Brossard, QC, June 27, 2008– Railpower Technologies Corp. (TSX: P) (the “Corporation”) is pleased to announce that it has closed its previously announced $20 Million private placement with Teachers. The proceeds will be used to finance, among other things, construction of a manufacturing facility in Saint- Jean-sur-Richelieu.

Victoria, B.C., June 26, 2008 – CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it will issue 3,500,000 units at a price of $0.10 per unit for gross proceeds of $350,000. The proceeds are intended to replace the funds that were expected to be received by the Company under the fourth and final tranche of the Company’s previously announced convertible note financing, which fourth tranche will not be completed.

VANCOUVER, June 26 - OneMove Technologies Inc. ("OneMove" or the "Company") (TSX-V: OM), a provider of a leading web-based real estate transaction platform, today announces plans to conduct a non-brokered private placement for total proceeds of up to $400,000.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

VANCOUVER, BC – June 20, 2008 – IP Applications Corp. (the “Company”) (IPX: TSX-V) today announces that it intends, subject to receipt of all necessary regulatory approvals, to complete a non-brokered private placement to raise between $750,000 and $1,500,000 through the issuance of up to 7,500,00 units at a price of $0.20 per unit (the “Offering”).

Vancouver, BC (June 16th, 2008) – Chemokine Therapeutics Corp. (the “Company”) (TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced that it has closed, via a non-brokered private placement, an offering of approximately 5,900,000 units at a price of $0.15 per unit for gross proceeds to the Company of approximately $885,000 (the “Offering”).

Vancouver, CANADA - SONIC Technology Solutions Inc. (?SONIC? or the ?Company?) today announced that it has closed the private placement (the “Placement”) first announced on May 12, 2008. Under the Placement, the Company issued an aggregate total of 5,249,332 units (the “Units”) to subscribers at a price of $0.30 per Unit, with each Unit consisting of one common share and one-half of one common share purchase warrant, for gross proceeds of approximately $1,574,800 (the “Proceeds”).